Indaptus Therapeutics INDP
NASDAQ INDP
$3.21 +0.31 (+10.69%)
At close: Nov 11, 2026 · 4:00 PM EST

Indaptus Therapeutics (INDP) Non Operating Interest Expenses (2020 - 2021)

Updated

Indaptus Therapeutics (INDP) reported Non Operating Interest Expenses of -$35,000 for Q2 2021, compared with $4,000 a year earlier.

Analysis

Indaptus Therapeutics (INDP) Non Operating Interest Expenses (2020 - 2021) Analysis & Trends

Over the twelve months ended Jun 30, 2021, Indaptus Therapeutics' Non Operating Interest Expenses came in at -$132,000.

  • The Q2 2021 figure ranks as the lowest quarterly Non Operating Interest Expenses since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Indaptus Therapeutics 185.93 Mn 158.54 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -35,000.00
Mar 31, 2021 -31,000.00
Jun 30, 2020 4,000.00
Mar 31, 2020 -70,000.00
API Access

Indaptus Therapeutics Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=INDP&period=max&api_key=YOUR_API_KEY